Opioid use, unspecified with opioid-induced sleep disorder
ICD-10 F11.982 is a billable code used to indicate a diagnosis of opioid use, unspecified with opioid-induced sleep disorder.
F11.982 refers to a condition characterized by the use of opioids, which are substances that can lead to addiction and various health complications. This specific code indicates that the individual is experiencing an unspecified opioid use disorder alongside an opioid-induced sleep disorder. Opioid use disorder is a medical condition that arises from the compulsive use of opioids, leading to significant impairment or distress. Symptoms may include cravings, withdrawal symptoms, and continued use despite negative consequences. The opioid-induced sleep disorder is a secondary condition that manifests as disturbances in sleep patterns, such as insomnia or excessive sleepiness, directly linked to opioid use. This code is crucial for identifying patients who may require specialized treatment programs, including behavioral therapy, medication-assisted treatment, and comprehensive management of both the substance use disorder and its associated sleep disturbances.
Thorough documentation of substance use history, treatment plans, and outcomes.
Patients presenting with withdrawal symptoms, cravings, or complications from opioid use.
Consideration of co-occurring disorders and comprehensive treatment approaches.
Detailed sleep studies and assessments of sleep patterns and disturbances.
Patients with sleep apnea or insomnia linked to opioid use.
Need for collaboration with addiction specialists for integrated care.
Used when assessing a patient for opioid use disorder and sleep disturbances.
Detailed notes on assessment findings and treatment recommendations.
Addiction specialists should document the comprehensive nature of the assessment.
Coding F11.982 is crucial for accurately representing a patient's condition, ensuring appropriate treatment and management of both opioid use disorder and associated sleep disturbances.
